17-12917329-G-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_014859.6(ARHGAP44):​c.387+1318G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.224 in 153,760 control chromosomes in the GnomAD database, including 6,805 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.23 ( 6790 hom., cov: 32)
Exomes 𝑓: 0.11 ( 15 hom. )

Consequence

ARHGAP44
NM_014859.6 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.379

Publications

13 publications found
Variant links:
Genes affected
ARHGAP44 (HGNC:29096): (Rho GTPase activating protein 44) Enables phospholipid binding activity. Predicted to be involved in several processes, including modification of dendritic spine; negative regulation of Rac protein signal transduction; and regulation of plasma membrane bounded cell projection organization. Located in leading edge membrane. [provided by Alliance of Genome Resources, Apr 2022]
MIR1269B (HGNC:41787): (microRNA 1269b) microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.96).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.511 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ARHGAP44NM_014859.6 linkc.387+1318G>C intron_variant Intron 5 of 20 ENST00000379672.10 NP_055674.4 Q17R89-1Q69Z00

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ARHGAP44ENST00000379672.10 linkc.387+1318G>C intron_variant Intron 5 of 20 1 NM_014859.6 ENSP00000368994.5 Q17R89-1

Frequencies

GnomAD3 genomes
AF:
0.225
AC:
34243
AN:
151984
Hom.:
6769
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.517
Gnomad AMI
AF:
0.00439
Gnomad AMR
AF:
0.156
Gnomad ASJ
AF:
0.165
Gnomad EAS
AF:
0.430
Gnomad SAS
AF:
0.297
Gnomad FIN
AF:
0.0830
Gnomad MID
AF:
0.101
Gnomad NFE
AF:
0.0733
Gnomad OTH
AF:
0.183
GnomAD2 exomes
AF:
0.0824
AC:
30
AN:
364
AF XY:
0.0750
show subpopulations
Gnomad AFR exome
AF:
0.500
Gnomad EAS exome
AF:
0.00
Gnomad NFE exome
AF:
0.0833
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.107
AC:
178
AN:
1658
Hom.:
15
Cov.:
0
AF XY:
0.109
AC XY:
103
AN XY:
948
show subpopulations
African (AFR)
AF:
0.367
AC:
22
AN:
60
American (AMR)
AF:
0.286
AC:
4
AN:
14
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
6
East Asian (EAS)
AF:
0.500
AC:
9
AN:
18
South Asian (SAS)
AF:
0.273
AC:
12
AN:
44
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
4
Middle Eastern (MID)
AF:
0.0920
AC:
71
AN:
772
European-Non Finnish (NFE)
AF:
0.0639
AC:
39
AN:
610
Other (OTH)
AF:
0.162
AC:
21
AN:
130
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.527
Heterozygous variant carriers
0
8
17
25
34
42
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.226
AC:
34305
AN:
152102
Hom.:
6790
Cov.:
32
AF XY:
0.227
AC XY:
16865
AN XY:
74356
show subpopulations
African (AFR)
AF:
0.517
AC:
21424
AN:
41468
American (AMR)
AF:
0.156
AC:
2382
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.165
AC:
574
AN:
3470
East Asian (EAS)
AF:
0.431
AC:
2218
AN:
5146
South Asian (SAS)
AF:
0.296
AC:
1424
AN:
4818
European-Finnish (FIN)
AF:
0.0830
AC:
878
AN:
10584
Middle Eastern (MID)
AF:
0.105
AC:
31
AN:
294
European-Non Finnish (NFE)
AF:
0.0733
AC:
4983
AN:
68020
Other (OTH)
AF:
0.184
AC:
387
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1065
2131
3196
4262
5327
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
318
636
954
1272
1590
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.142
Hom.:
425
Bravo
AF:
0.241
Asia WGS
AF:
0.353
AC:
1226
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.96
CADD
Benign
0.93
DANN
Benign
0.54
PhyloP100
-0.38
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7210937; hg19: chr17-12820646; API